Skip to main navigation

Overview
News & Events
Stock
Governance
Financials
IR Resources
Stock Feed

Investor Relations

Latest Earnings Latest Annual Report

Overview

Tenax Therapeutics is a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies.

News Releases

Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

March 10, 2026

Read More

Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference

March 3, 2026

Read More

Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026

February 4, 2026

Read More

All News Releases

Corporate Presentation

Corporate Presentation March 2026

Q4 2025 Results

Earnings Release
Form 10-K

All Quarterly Results

Events

There are no upcoming events scheduled at this time.

Past Events

2026 Leerink Partners Global Healthcare Conference

March 10, 2026 2:20 PM EDT

Past Events

Guggenheim Emerging Outlook: Biotech Summit 2026

February 11, 2026 12:30 PM EST

Past Events

Piper Sandler 37th Annual Healthcare Conference

December 4, 2025 11:30 AM EST

All Events

Investor Contact

Argot Partners

draftstenax@argotpartners.com

phone_iphone +1 212-600-1494

Subscribe to our Email Alerts

Email Address Required

© Tenax Therapeutics

|

Site Map

Search Investors

Search this site